Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2017 | Keeping a positive attitude against Alzheimer’s disease

Christine Van Broeckhoven • 14 Aug 2017
AAIC 2017
Alzheimer’s Disease

When individuals learn that they carry a mutation linked to the development of Alzheimer’s disease, the news can be devastating and can severely impact their quality of life. Christine Van Broeckhoven, PhD, DSc from the Neurodegenerative Brain Diseases Group, VIP, Antwerp, Belgium discusses the role that intervention studies play in keeping a positive attitude for these individuals, and the importance of these measures on disease progression. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) held in London, UK.

More from Christine Van Broeckhoven

Emerging trends at AAIC
0:52
Emerging trends at AAIC
Christine Van Broeckhoven • 14 Aug 2017
Could the onset age of Alzheimer's disease be modified?
2:09
Could the onset age of Alzheimer's disease be modified?
Christine Van Broeckhoven • 14 Aug 2017
ABCA7 mutations in dementia patients
1:05
ABCA7 mutations in dementia patients
Christine Van Broeckhoven • 14 Aug 2017
Genes in Alzheimer’s disease: the challenge continues
5:07
Genes in Alzheimer’s disease: the challenge continues
Christine Van Broeckhoven • 14 Aug 2017

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
What are the biological mechanisms underlying the higher prevalence of AD in women?
1:55
What are the biological mechanisms underlying the higher prevalence of AD in women?
Amber Watts • 14 Jul 2026
MenoCog: risk and protective factors for cognitive function in the menopause transition
2:37
MenoCog: risk and protective factors for cognitive function in the menopause transition
Amber Watts • 14 Jul 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals